- Report
- August 2025
- 480 Pages
Global
From €5223EUR$5,850USD£4,559GBP
- Report
- August 2024
Japan, United States, ... Japan, United States, Europe
From €3125EUR$3,500USD£2,727GBP
- Report
- January 2023
- 119 Pages
Global
From €4017EUR$4,500USD£3,507GBP
- Report
- July 2024
- 86 Pages
Global
From €3500EUR$4,200USD£3,162GBP
- Report
- November 2024
Japan, United States, ... Japan, United States, Europe, Global
From €4017EUR$4,500USD£3,507GBP
- Report
- November 2024
Japan, United States, ... Japan, United States, Europe
From €1339EUR$1,500USD£1,169GBP
- Report
- October 2024
Global
From €3125EUR$3,500USD£2,727GBP
Yersinia Test is a type of infectious disease testing used to detect the presence of Yersinia bacteria in a patient's sample. Yersinia is a genus of bacteria that can cause a variety of illnesses, including plague, gastroenteritis, and septicemia. Yersinia tests are used to diagnose and monitor the progression of these illnesses. The test is typically performed on a sample of blood, urine, or tissue.
Yersinia tests are used in both clinical and research settings. In clinical settings, the test is used to diagnose and monitor the progression of Yersinia-related illnesses. In research settings, the test is used to study the epidemiology of Yersinia-related illnesses and to develop new treatments.
The Yersinia Test market is composed of a variety of companies that provide testing services, reagents, and other related products. Examples of companies in the market include Bio-Rad Laboratories, Thermo Fisher Scientific, Abbott Laboratories, and Becton Dickinson. Show Less Read more